Bottom line
PCHSX vs FHLC: the short answer
PCHSX (Putnam Global Health Care Fund) and FHLC (Fidelity MSCI Health Care Index ETF) are both mutual funds.
But FHLC is far broader, holding 337 positions to 115 for PCHSX, so beyond the top names it adds exposure PCHSX doesn't have.
FHLC is cheaper at 0.084% vs 1.79% — a difference of $171 a year per $10,000 invested.
Over five years, FHLC returned +7.2% a year vs +7.0% for PCHSX (reporting dates differ).
Updated Nov 19, 2026
PCHSX vs FHLC side by side
| PCHSX | FHLC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Franklin Templeton | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.79% | 0.084% |
| Annual cost per $10k | $179 | $8.4 |
| 10-yr cost on $10k (prospectus) | $1,909 | $108 |
| Max front load | 0% | None |
| 12b-1 fee | 1% | 0% |
| 1-yr return | −0.4% | +2.6% |
| 5-yr return (annualized) | +7.0% | +7.2% |
| 10-yr return (annualized) | +6.9% | +8.8% |
| Best quarter | — | +16.4% |
| Worst quarter | — | −13.1% |
| Net assets (fund) | $1.5B | $3.3B |
| Number of holdings | 115 | 337 |
| Portfolio turnover | 67% | 3% |
| Returns as of | Dec 31, 2024 | Nov 30, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
16 of PCHSX's top 25 holdings also appear in FHLC's top 25.
| Holding | PCHSX | FHLC |
|---|---|---|
| Eli Lilly & Co. | 13.15% | 13.35% |
| Johnson & Johnson | 8.46% | 8.93% |
| UnitedHealth Group, Inc. | 6.93% | 5.44% |
| AbbVie, Inc. | 6.05% | 6.42% |
| Merck & Co., Inc. | 4.88% | 4.66% |
| Thermo Fisher Scientific, Inc. | 4.50% | 3.09% |
| Intuitive Surgical, Inc. | 4.04% | 1.82% |
| CVS Health Corp. | 2.74% | 1.92% |
| Gilead Sciences, Inc. | 2.63% | 2.34% |
| McKesson Corp. | 2.14% | 1.52% |
| Cardinal Health, Inc. | 2.12% | 0.78% |
| Vertex Pharmaceuticals, Inc. | 1.97% | 1.76% |
| Boston Scientific Corp. | 1.80% | 1.00% |
| Bristol-Myers Squibb Co. | 1.75% | 1.93% |
| HCA Healthcare, Inc. | 1.18% | 0.91% |
Source: SEC Form N-PORT
PCHSX top 10
- Eli Lilly & Co. — 13.15%
- Johnson & Johnson — 8.46%
- UnitedHealth Group, Inc. — 6.93%
- AbbVie, Inc. — 6.05%
- Novartis AG — 5.13%
- Merck & Co., Inc. — 4.88%
- AstraZeneca plc — 4.67%
- Thermo Fisher Scientific, Inc. — 4.50%
- Intuitive Surgical, Inc. — 4.04%
- Sanofi SA — 3.23%
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
FAQ
What is the difference between PCHSX and FHLC?
Which is cheaper, PCHSX or FHLC?
Should I own both PCHSX and FHLC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.